T1	Participants 210 250	44 patients with inclusion body myositis
T2	Participants 38 61	inclusion body myositis
T3	Participants 840 968	We conclude that oral methotrexate did not slow down progression of muscle weakness but decreased serum creatine kinase activity
T4	Participants 820 838	methotrexate group
